ATNM icon

Actinium Pharmaceuticals
ATNM

Overview Fund Activity

30 hedge funds and large institutions have $5.2M invested in Actinium Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.

Holders
30
Holders Change
+6
Holders Change %
+25%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
6
Closed
1
Calls
$234K
Puts
$70K
Net Calls
+$164K
Net Calls Change
+$323K

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.64M
2
BCM
2
Bridgeway Capital Management
Texas
$478K
3
DADC
3
D.A. Davidson & Co
Montana
$179K
4
VKH
4
Virtu KCG Holdings
New York
$51K
5
Nomura Holdings
5
Nomura Holdings
Japan
$41K

Top Sellers

1
OAM
1
Oxford Asset Management
United Kingdom
$24K
2
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$5K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$64K
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$0
5
Group One Trading
5
Group One Trading
Illinois
$2K
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
26
Group One Trading
Illinois
$2K 945 -7,317 -89%
AIM
27
Acrospire Investment Management
Illinois
$2K 1,100 +1,100 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$301 151,287 – –
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
– – -10,570 Closed
Parallax Volatility Advisers
30
Parallax Volatility Advisers
California
– – – –
ST
31
Spot Trading
Illinois
– – – –
JPMorgan Chase & Co
32
JPMorgan Chase & Co
New York
$0 100 +100 New
Citigroup
33
Citigroup
New York
$0 125 +125 New
1
2